Clinical Medicine 2015 Vol 15, No 3: s19 CLINICAL RESEARCH AND CASE REPORTS
Results
33% of patients died, highlighting the high mortality rate in this population. On the second discharge, 72% of patients did not have an adequately controlled heart rate (defi ned as <75 bpm), and the average heart rate was 78 bpm. Of those whose heart rate was not controlled, 24 would be suitable for ivabradine.
Conclusions
The evidence base for improved mortality and morbidity for heart rate control in heart failure is well demonstrated, and thus heart rate needs to be controlled. Despite two hospital admissions, and two opportunities to target heart rate, it is not being appropriately controlled prior to discharge.
Another consideration is the early role for ivabradine in heart rate control, rather than waiting until the failed up-titration of beta blockers, which is a notoriously diffi cult task.
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